- Home
- ELMD vs IDYA Comparison
ELMD vs IDYA Comparison
Compare ELMD & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- IDYA
- Stock Information
- Founded
- ELMD 1992
- IDYA 2015
- Country
- ELMD United States
- IDYA United States
- Employees
- ELMD N/A
- IDYA N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- IDYA Health Care
- Exchange
- ELMD Nasdaq
- IDYA Nasdaq
- Market Cap
- ELMD N/A
- IDYA 2.2B
- IPO Year
- ELMD 2010
- IDYA 2019
- Fundamental
- Price
- ELMD $27.73
- IDYA $26.23
- Analyst Decision
- ELMD
- IDYA Strong Buy
- Analyst Count
- ELMD 0
- IDYA 12
- Target Price
- ELMD N/A
- IDYA $53.67
- AVG Volume (30 Days)
- ELMD 92.7K
- IDYA 1.0M
- Earning Date
- ELMD 02-11-2025
- IDYA 11-04-2024
- Dividend Yield
- ELMD N/A
- IDYA N/A
- EPS Growth
- ELMD 94.54
- IDYA N/A
- EPS
- ELMD 0.72
- IDYA N/A
- Revenue
- ELMD $57,060,000.00
- IDYA $3,922,000.00
- Revenue This Year
- ELMD $14.27
- IDYA N/A
- Revenue Next Year
- ELMD N/A
- IDYA $251.89
- P/E Ratio
- ELMD $38.26
- IDYA N/A
- Revenue Growth
- ELMD 14.73
- IDYA N/A
- 52 Week Low
- ELMD $9.81
- IDYA $24.48
- 52 Week High
- ELMD $31.31
- IDYA $47.74
- Technical
- Relative Strength Index (RSI)
- ELMD 48.70
- IDYA 37.58
- Support Level
- ELMD $26.91
- IDYA $24.48
- Resistance Level
- ELMD $28.98
- IDYA $27.15
- Average True Range (ATR)
- ELMD 1.22
- IDYA 1.34
- MACD
- ELMD -0.45
- IDYA -0.11
- Stochastic Oscillator
- ELMD 21.93
- IDYA 7.90
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.